Finance Archives - BioPharmaJournal

Pasithea Therapeutics Corp (NASDAQ: KTTA) Expands IV Ketamine Therapy Availability In...

Kate Hudson - December 20, 2021 0

Karyopharm Therapeutics Inc. (NASDAQ: KPTI) Doses Subjects In Study Evaluating selinexor...

Gavins Felicity - December 15, 2021 0

Ionis Pharmaceuticals Inc. (NASDAQ: IONS) Announce Update Regarding Vupanorsen Study In...

Matt Wade - December 8, 2021 0

Inhibikase Therapeutics Inc. (NASDAQ: IKT) Publishes Study Showing Oral c-Abl Kinase...

Gavins Felicity - December 7, 2021 0

Time to Revisit Previously Booming CBD Space for Big Growth on...

Matt Wade - December 3, 2021 0

Bitcoin Stocks Primed as Inflation Concerns Build (BKKT, ISWH, RIOT, MARA,...

Kate Hudson - December 3, 2021 0

Top Clean Energy Stocks are On Sale and Structurally Favored (CLNE,...

Gavins Felicity - December 3, 2021 0

Timber Pharmaceuticals Inc. (NYSEAMERICAN: TMBR) Reports Results From TMB-001 Study And...

Gavins Felicity - December 3, 2021 0

Biotech Growth Stocks Set to Benefit from Rising Volatility (REGN, OTLC,...

Ash K - December 2, 2021 0

Spotlight on Top Stocks in the Growing Sports Nutrition Space (USNA,...

Matt Wade - December 2, 2021 0

12 3...13 Page 1 of 13

CymaBay Therapeutics Inc (NASDAQ: CBAY) Announces Promising Seladelpar Data In Treatment...

Gavins Felicity - July 5, 2022 0

CymaBay Therapeutics Inc (NASDAQ: CBAY) has announced the presentation of promising seladelpar findings in primary biliary cholangitis (PBC) patients at The International Liver Congress...

Chimerix Inc (NASDAQ: CMRX) Receives $25.3 Million Procurement Contract For TEMBEXA

July 4, 2022

Regulus Therapeutics Inc (NASDAQ: RGLS) Pleased after FDA Approved its Orphan...

July 1, 2022

Cannabis Stocks Deeply Oversold with Big Growth Ahead (TLRY, SGMD, OGI,...

June 30, 2022

Ocugen Inc (NASDAQ: OCGN) Announces the Successful Publication of Positive Outcomes...

June 30, 2022

Finance

Recent Post